Patent Assignment
Reel/Frame 026235/0568
Assignment of Assignor's Interest
Recorded: 2011-05-06
Pages: 34
Assignor
VION PHARMACEUTICALS, INC.
Executed: 2011-01-24
Assignee
NANOTHERAPEUTICS, INC.
13859 PROGRESS BOULEVARD, SUITE 300, ALACHUA, FLORIDA, 32615
Covered Properties
(32)
Water-Soluble Shps as Novel Alkylating Agents
PCT:
PCT/US2004/015547 ↗
Combination Therapy Comprising Cloretazine
PCT:
PCT/US2005/010152 ↗
Phosphate-Bearing Prodrugs of Sulfonyl Hydrazines as Hypoxia-Selective Antineoplastic Agents
PCT:
PCT/US2005/033641 ↗
Processes for High-Yield Diastereoselective Synthesis of Dideoxynucleosides
Patent:
6,005,097 →
Application:
08/663,674 →
Process for the Synthesis of Ribonucleotide Reductase Inhibitors 3-Ap and 3-Amp
Patent:
5,869,676 →
Application:
08/856,559 →
Prodrug Forms of Ribonucleotide Reductase Inhibitors 3-Ap and 3-Amp
Patent:
5,767,134 →
Application:
08/856,568 →
Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules
Patent:
6,962,696 →
Application:
09/645,415 →
Compositions and methods for delivery of an agent using attenuated salmonella containing phage
Application:
09/645,418 →
Modified Prodrug Forms of Ap/Amp
Compositions and methods for delivery of an agent using attenuated Salmonella containing phage
Application:
10/076,117 →
Publication:
US 2003/0113293
Water-Soluble Shps as Novel Alkylating Agents
Combination Therapy Comprising Cloretazine
Compositions and methods for tumor-targeted delivery of effector molecules
Application:
10/738,423 →
Publication:
US 2004/0229338
Compositions and methods for delivery of an agent using attenuated Salmonella containing phage
Application:
10/790,586 →
Publication:
US 2004/0219169
Water-soluble SHPs as novel alkylating agents
Application:
10/950,890 →
Publication:
US 2005/0043244
Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules
Phosphate-Bearing Prodrugs of Sulfonyl Hydrazines as Hypoxia-Selective Antineoplastic Agents
Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules
Application:
11/627,743 →
Publication:
US 2007/0298012
Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents
Application:
12/080,357 →
Publication:
US 2009/0075945
Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules
Application:
12/254,122 →
Publication:
US 2009/0169517
Compositions and Methods for the Tumor-Targeted Delivery of Anti-Angiogenic Factors
Application:
60/157,500 →
Compositions and Method for Tumor-Targeted Bacteriocin Delivery
Application:
60/157,581 →
Non-Invasive Tumor Imaging by Tumor-Targeted Bacteria
Application:
60/157,620 →
Compositions and Methods for Tumor-Targeted Tnf Delivery
Application:
60/157,637 →
Modified prodrug forms of AP/AMP
Application:
60/240,529 →
Methods for treating cancer by administering tumor-targeted bacteria and an immunomodulatory agent
Application:
60/352,259 →
Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents
Application:
60/611,623 →
Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents
Application:
60/615,419 →
Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents
Application:
60/616,500 →
Alkylguanyltransferase assays
Application:
60/660,738 →
Alkylguanyl transferase assays
Application:
60/663,454 →
Methods of synthesizing VNP4010M
Application:
61/128,975 →
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 16, 2001
From: BERMUDES, DAVID G.; KING, IVAN C.; CLAIRMONT, CAROLINE A.; LIN, STANLEY L.
To: VION PHARMACEUTICALS, INC.
Reel/Frame 012277/0251 →
Assignment of Assignor's Interest
Jul 29, 2004
From: LIN, XU; DOYLE, TERRENCE W.; KING, IVAN
To: VION PHARMACEUTICALS, INC.
Reel/Frame 014923/0123 →
Assignment of Assignor's Interest
Jan 25, 2005
From: LIN, XU; KING, IVAN; DOYLE, TERRENCE W.
To: VION PHARMACEUTICALS, INC.
Reel/Frame 015620/0402 →
Assignment of Assignor's Interest
Jan 4, 2006
From: LIN, XU; KING, IVAN; BELCOURT, MICHAEL F.; DOYLE, TERRENCE W.
To: VION PHARMACEUTICALS, INC.
Reel/Frame 017162/0098 →
Assignment of Assignor's Interest
Feb 19, 2008
From: BERMUDES, DAVID G; KING, IVAN C; CLAIRMONT, CAROLINE A; LIN, STANLEY L
To: VION PHARMACEUTICALS, INC.
Reel/Frame 020524/0260 →
Assignment of Assignor's Interest
Jan 7, 2009
From: KING, IVAN; SZNOL, MARIO; BELCOURT, MICHAEL; ZHENG, LI-MOU
To: VION PHARMACEUTICALS, INC.
Reel/Frame 022067/0989 →
Assignment of Assignor's Interest
Mar 27, 2009
From: BERMUDES, DAVID G; KING, IVAN C; CLAIRMONT, CAROLINE A; LIN, STANLEY L
To: VION PHARMACEUTICALS, INC.
Reel/Frame 022463/0261 →
Assignment of Assignor's Interest
Mar 27, 2009
From: BERMUDES, DAVID G; KING, IVAN C; CLAIRMONT, CAROLINE A; LIN, STANLEY L
To: VION PHARMACEUTICALS, INC.
Reel/Frame 022462/0811 →
Assignment of Assignor's Interest
Mar 27, 2009
From: BERMUDES, DAVID G; KING, IVAN C; CLAIRMONT, CAROLINE A; LIN, STANLEY L
To: VION PHARMACEUTICALS, INC.
Reel/Frame 022463/0037 →
Security Interest
Mar 20, 2015
From: NANOTHERAPEUTICS, INC.
To: WHITE OAK GLOBAL ADVISORS, LLC
Reel/Frame 035236/0932 →
Release of Security Interest
May 19, 2016
From: WHITE OAK GLOBAL ADVISORS, LLC AS AGENT
To: NANOTHERAPEUTICS, INC.
Reel/Frame 038651/0947 →
Assignment of Assignor's Interest
Aug 22, 2018
From: NANOTHERAPEUTICS INC
To: NANOSHIFT, LLC
Reel/Frame 046656/0784 →